QUOTE AND NEWS
SeekingAlpha  Oct 29  Comment 
GenEng News  Oct 21  Comment 
NeoGenomics said today it has agreed to acquire Clarient and its wholly-owned subsidiary Clarient Diagnostic Services from GE Healthcare. The deal, valued at up to $275.2 million, is intended to create a larger and broader provider of precision...
Mondo Visione  Oct 6  Comment 
Clarient, the industry-owned client data and documentation utility, and the FIA Technology Services, Inc. (FIA Tech), a wholly owned subsidiary of the Futures Industry Association, have partnered to introduce a streamlined solution to simplify the...
Mondo Visione  Sep 9  Comment 
The Securities and Exchange Commission today charged a father, son, and friend in Northern California with insider trading in advance of a merger of health care companies based on confidential information the father learned from a close friend...
Mondo Visione  Jul 29  Comment 
New industry solution, Clarient Entity Hub, to provide centralized services for all client data and documents needed to satisfy internal on-boarding and help firms meet broader related regulatory requirements including Know Your Customer (KYC),...
StreetInsider.com  Apr 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Clarient+Enters+Partnership+to+Distribute+CombiMatrix%27s+%28CBMX%29+DNAarray+Products/6420547.html for the full story.
Globe Newswire  Apr 11  Comment 
IRVINE, Calif., April 11, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into a strategic partnership with Clarient, Inc., a GE Healthcare Company, that allows Clarient the right to commercialize
Penny Stock DD  Dec 4  Comment 
(RTTNews) - GE Healthcare, a unit of General Electric Co. (GE), said Friday that it is extending its tender offer for all of the outstanding capital stock of Clarient, Inc. (CLRT) to December 16. The tender offer has been extended to allow...
FierceBiotech  Oct 25  Comment 
GE on Friday announced plans to buy Clarient--a molecular diagnostics company with a strong focus on cancer markers--for $587 million. GE Healthcare is planning to build itself into a billion-dollar business marketing diagnostic solutions for...




RELATED WIKI ARTICLES

Related Articles


You may also be interested in articles related to Clarient (CLRT):

 
Clarient (CLRT) provides a services to assess cancer on a cellular level and to characterize the cancer. They primarily focus on solid tumors on the breast, prostate and lung.

Nov 30,2009:- Clarient Inc. has signed an exclusive license to technology aimed at making better tests for cancer. The company said it licensed a test that can identify the MUC1 protein from privately held Minerva Biotechnologies. The protein is a potential biomarker that could help identify various types of cancer. Financial terms of the deal were not disclosed. Clarient is the leading medical device maker in MUC1 protein. Clarient is investing in further developing MUC1 protein.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki